Proa Medical's advisors have expertise and experience in numerous areas including medicine, public health, business strategy, marketing, distribution, intellectual property, and corporate law.
Jonathan G. Lasch, PhD
Business and Technology Advisor
Dr. Lasch is the Executive Director for the Alfred E. Mann Institute for Biomedical Engineering at the University of Southern California (AMI-USC), where he brings more than 25 years of experience in science and technology development and evaluation in the fields of biomedical instruments and systems, biotechnology, chemistry, and materials science.
He is a Research Professor of Biomedical Engineering in the Viterbi School of Engineering, and a Professor of Clinical Entrepreneurship in the Greif Center of the Marshall School of Business at USC.
Prior to joining AMI-USC he served as a Managing Director of Convergent Ventures (CV), an early stage life sciences venture investment and development company. While at Convergent Ventures, he served as chairman of the board and CEO of ORFID Corporation, and was the founding CEO and a member of the board of directors of Neurion Pharmaceuticals, Inc. Also he is a director of Encode Bio, Inc., a CV portfolio company.
From 2002-2007, Dr. Lasch was on the board of directors of Precision Dynamics Corporation, a privately held healthcare products company, and he currently serves on the board of directors of the Southern California Biomedical Council. Dr. Lasch has held leadership positions at Materia, a materials science company spun out of Caltech, where he served as founding President and CEO, and Cyrano Sciences, a Caltech spin-out based on chemical sensor technology.
Previously, he served as vice president, technology development for The Scripps Research Institute, the largest not-for-profit biomedical research institute in the United States and was director of research, biotechnology, for PPG Industries.
From 2004 through 2008, he served on the faculty of the UCLA Anderson School of Management, in the FEMBA GAP program and for two years as the Director of the EMBA Field Study Program.
Jon received his BS in Biological Science from the University of Texas at El Paso, and his PhD in Chemistry from the University of Texas at Austin, and is a Fellow of the American Institute for Medical and Biological Engineering.
Board of Directors
Mr. Hutchinson is an entrepreneurial executive with over 25 years of experience in the healthcare technology field. His experience includes founder and CEO, board directorships, investment advisor and consultant for numerous healthcare and technology-oriented start up’s as well as established healthcare manufacturing companies. As an investment advisor, Hutchinson has worked with Hambrecht & Quist, Houlihan Lokey Howard & Zukin, Convergent Ventures, WR Hambrecht & Co. and Water Street Healthcare Partners.
Mr. Hutchinson’s operating experience includes President and CEO of Precision Dynamics Corporation (PDC), the leading manufacturer of healthcare and patron management identification solutions from 2002 until mid October 2010. Under Hutchinson’s direction, PDC grew from $43M to $112M in sales / $2M to $16M in EBITDA.
Prior to PDC, Hutchinson was a founder of Zymed Medical Systems (now Philips Medical Systems, acquired 2000). Through technology development and strategic alliances, the company became the industry leader in Ambulatory Monitoring and Arrhythmia Detection Algorithms. The company grew to $25M in sales / $5M in EBITDA. Following the acquisition, Hutchinson served as VP Cardiology Products for Philips Medical Systems. The $200M business unit was responsible for manufacturing, research and development, sales and marketing world-wide for non-invasive cardiology products.
Mr. Hutchinson’s experience also includes serving on various Advisory Boards. Gary’s Board of Director experience includes Advamed, a healthcare industry advocacy organization and Quinton Instruments, a leading company in Stress Testing, Cardiac Rehab and Cardiac Imaging Systems. Further he was an investor with HP, WRHambrecht & Zymed leading a buyout of Quinton from American Home Products.
Mr. Hutchinson’s community service experience includes serving on the Board of Directors for Big Brothers and Big Sisters of Greater Los Angeles and Louisville High School Finance Council in Woodland Hills, CA. He is a graduate of Ohio State.
James Greenberg, MD
Dr. Greenberg is Board certified in obstetrics and gynecology. He serves on the faculty at Harvard Medical School where he is an Associate Professor. Since 2000, Dr. Greenberg has served as Chief of Gynecology at the Faulkner Hospital and a Vice Chairman of Obstetrics & Gynecology at Brigham & Women’s Hospital. Dr. Greenberg was named as a “Top Doc” in 2010, 2011, 2012, 2013 and 2014 by Boston Magazine.
Dr. Greenberg is a member of the American Medical Association (AMA), the American College of Ob/Gyn (ACOG), the American Association of Gynecologic Laparoscopists (AAGL), the Society of Laparoendoscopic Surgeons (SLS), and the Society of Robotic Surgeons (SRS).
Dr. Jim Greenberg received his undergraduate B.A. degree in 1984 from Amherst College, his M.D. degree from New York University School of Medicine, and did his residency training in Obstetrics & Gynecology at the Brigham & Women’s and Massachusetts General Hospitals from 1988 to 1992.
Throughout his career, Dr. Greenberg has also been engaged in clinical research as a physician-scientist, co-authoring over 50 publications, abstracts and videos on a variety of topics including minimally invasive surgery, fibroids, hysteroscopy, hysterectomy, laparoscopy, suture materials. Dr. Greenberg has also been active overseas doing global medicine work in Qatar, Ethiopia, and Rwanda.
Kate Gaynor, MD, MBA
Dr. Kate Gaynor is a board certified Family Medicine Physician and General Manager of the United Family Guangzhou Clinic. She has worked previously at Hawaii Disaster Medical Assistance Team, the Waianae Coast Comprehensive Health Center, and the Hawaii State Department of Health.
Dr. Gaynor received her bachelor of arts from Yale University and attended Columbia University’s College of Physicians and Surgeons for her medical degree. Dr. Gaynor completed a residency in family medicine at the University Of Washington. Dr. Gaynor also obtained a Global Executive MBA from the University of Southern California Marshall School of Business.
Duffy Casey, MD
Dr. Casey is board certified in obstetrics and gynecology. He is a co-founder and Medical Director of Global Brigades, Inc., an international non-profit that empowers communities to meet their health and economic goals through university volunteers and local teams. Global Brigades is the world’s largest student-led global health and sustainable development organization.
Dr. Casey completed his undergraduate degree from the University of Wisconsin, and his medical degree from Eastern Virginal Medical School. He completed his residency and fellowship at the University of Hawaii and currently practices at Maui Memorial Medical Center.
Lyndee Knox, PhD
Health Policy Advisor
Lyndee Knox, PhD is founding director of LA Net, a primary care practice based research and resource network in LA County. She worked as a clinical psychologist for 12 years in health care and school environments in Texas; and was an Associate Professor of Family Medicine at the University of Southern California for 10 years.
LA Net is a primary care practice-based research network that supports practice based, clinician led research, evidence translation and practice improvement transformation in the safety net. Twenty-four organizations, mainly Federally Qualified Health Centers, currently participate in LA Net, representing 116 practice sites and delivering more than 1.2 million patient visits a year. As part of its work, LA Net provides practice facilitators to safety net practices to support quality improvement, research and evidence translation.
In addition to her work with practice improvement, Dr. Knox is an expert in community health workers interventions. She has served as Co-Director for the CDC-funded Southern California Center for Academic Excellence in Youth Violence Prevention for 10 years; and as an advisor to the Centers for Disease Control and Prevention, the Health Resources and Services Administration, the American Academy of Pediatrics, and the American Medical Association on health disparities related topics.
Dr. Knox received her Ph.D. in Psychology from the University of Texas at Austin in 1999 and has been awarded research fellowships from the University of Texas-Austin, the Hogg Foundation for Mental Health, Harvard University, the University of Southern California, and the American Psychological Association.
Mads Fiig is an international business developer with over 20 years of experience developing and implementing successful growth strategies for exporting medical device manufacturers. Mr. Fiig is highly skilled in providing cost effective market access resulting in strong revenue growth in EMEA and APAC markets.
Mr. Fiig’s experience includes management of manufacturing business focusing on international distributor sales. As Vice President International of Precision Dynamics Corp. (PDC), Mr. Fiig was responsible for all markets outside USA and Canada, managing distributors in over 150 countries through five direct reports. Also under Mr. Fiig’s responsibility was the PDC Europe and International head office, located in Belgium, which included a manufacturing and distribution center with a $21M budget and staff of 50.
In his prior position as Managing Director of PDC, Mr. Fiig managed daily operations as the company went through two acquisitions and following integrations.
Previously, Mr. Mads Fiig had founded MFR Europe Sprl., initially operating as an agent for PDC while adding its own product lines. Mr. Fiig developed the business into a distributorship covering EMEA, focused on US manufactured medical device disposables for the OR, and sold MFR to Precision Dynamics Corp. in 2004.
Mr. Fiig’s areas of expertise include: go-to-market strategy, development and implementation; sales channel development and management; sales and marketing research; CE Mark and regulatory assistance; set-up and distribution centers; and acquisition targets search.
Richard Hull, PhD
Dr. Hull has over twenty years of experience with entrepreneurial ventures and technology development from the perspectives of investor, owner, CEO and consultant.
Richard Hull is Founder and CEO of The Metaphase Group, which assists companies to formulate strategies, access capital, and realize value; with a focus on technology-driven and science-based companies in the healthcare, environmental and high-tech sectors.
Dr. Hull has served as Senior Director New Ventures & Alliances at the University of Southern California, supporting USC's strategic priority of promoting innovation and startup creation. Richard worked with faculty and students to advance their ideas, managed for a period of time the licensing and technology transfer program, and developed the broader innovation ‘ecosystem’ to support these endeavors. Previously, Dr. Hull served as President and CEO of Spotlight Health, a Healthcare communications company delivering integrated marketing campaigns using celebrity patient advocates, public relations, the web and other tactics to educate and change consumer and physician behavior.
Richard Hull earned a Bachelor’s Degree from Cambridge University and a PhD in Biochemistry from Oxford University.
Louis Dienes, JD
Louis Dienes, an attorney at Ballard Spahr, provides legal services to Proa Medical for private placements, corporate legal issues, and related services. He is a trusted advisor to boards, senior management, investment banks and investors in mergers, acquisitions and divestitures, equity and debt financings, and business operations.
Mr. Dienes has represented buyers and sellers and their respective boards, senior management, investment banks and other stakeholders such as debt holders in more than $10 billion of consummated mergers, acquisitions and divestitures, including U.S. and foreign stock and asset acquisitions and mergers. He has substantial experience in transactions involving technology and other intellectual property assets of distressed businesses bought or sold through foreclosures, assignments for the benefit of creditors, receiverships, bankruptcy and as U.S. co-counsel in analogous foreign transactions.
He has represented businesses, investment banks and investors in more than 150 private offerings of securities, including preferred stock offerings, convertible debt offerings and offerings of partnership and limited liability company securities as well as acting as U.S. co-counsel in foreign private offerings of securities, with substantial experience advising private investor groups and angel investors.
Mr. Dienes is the primary legal advisor to the boards and senior management of, and investors in, U.S. and foreign businesses, ranging from start-ups to multinationals. Louis Dienes earned a Bachelor’s Degree from the University of California, Berkeley and a Juris Doctor from Stanford Law School.